Skip to main content
OpenTrials

Clinical trial condition

Gastro-enteropancreatic neuroendocrine tumor

Explore clinical trials studying Gastro-enteropancreatic neuroendocrine tumor. Study availability and eligibility vary by location and protocol.

46 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Gastro-enteropancreatic neuroendocrine tumor trial results

Recruiting

Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort

NCT06256705

Conditions
Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor, Radiotherapy
Locations
  • Médecine nucléaire et Biophysique - Beaujon Clichy, France
  • Pancréatologie et Oncologie Digestive - Beaujon Clichy, France
  • Hépato-gastro-entérologie, cancérologie digestive et assistance nutritionnelle - CHU Nantes Nantes, France
  • Médecine nucléaire - CHU Nantes Nantes, France
View Trial Details
Recruiting

Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients

NCT05701241

Conditions
Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor, Neoplasms, +5 more
Locations
  • AZ Klina Brasschaat, Antwerp, Belgium
  • AZ Rivierenland Rumst, Antwerp, Belgium
  • Ghent University Hospital Ghent, East Flanders, Belgium
  • VITAZ Sint-Niklaas, East-Flanders, Belgium
View all 19 locations
View Trial Details
Recruiting

Spanish Series of Patients Treated With the Radionuclide Lutetium177

NCT04949282

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +19 more
Locations
  • Hospital Clínico Universitario de Santiago Santiago de Compostela, A Coruña, Spain
  • Hospital Universitario Virgen de las Nieves Granada, Andalusia, Spain
  • Hospital Unviersitari Son Espases Palma de Mallorca, Balearic Islands, Spain
  • Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain
View all 20 locations
View Trial Details
Enrolling by invitation

Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET

NCT05385861

Conditions
GEP-NET, Gastro-enteropancreatic neuroendocrine tumor
Locations
  • Chang-Gung Memorial Hospital, Kaohsiung Kaohsiung City, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • Chang Gung Memorial Hospital (Lin-Kou), Linkou District, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View Trial Details
Active, not recruiting

Neuroendocrine Tumors - Patient Reported Outcomes

NCT05064150

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of Kansas Medical Center Research Institute, Inc Kansas City, Kansas, United States
  • Regents of the University of Michigan Ann Arbor, Michigan, United States
View all 14 locations
View Trial Details

Related conditions